Purchase Order 75N92E19P00124
Award Date 6/12/19
Potential Completion Date 6/11/20
Potential Value Not listed
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $57,000 purchase order to Oxford Nanopore Technologies Inc. to procure Grid ION Mk1 sequencing devices. The one-year firm fixed price contract, running from July 2021 through July 2022, will provide the sequencing devices requested in Solicitation Number NIH-NHGRI-21-100-SOL titled "To Procure Grid ION Mk1 Sequencing Device." As the parent agency of the...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the delivery of reagents to assist investigators working to sequence unresolved regions of the human genome. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded several...
- This federal contract award was made by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $376,365.00 firm fixed-price purchase order is for the delivery of PromethION Instrument Reagents, which support the agency's genomic research and analysis work. The contract has an ultimate completion date of June 30, 2026 and does not utilize any...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
- This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...
- This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the procurement of 8 packs of 4 PROMETHION flow cells for RNA sequencing. This appears to be part of a larger Indefinite Delivery Vehicle (IDV) that Oxford Nanopore has with the NHGRI, as the company has...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Human Genome Research Institute to Oxford Nanopore Technologies Inc. for a PROMETHION 24 system. The contract has a completion date of July 31, 2019 and a potential value of $165,000.00. The contract does not have a set-aside designation. Based on Oxford Nanopore Technologies Inc.'s past federal contract work, they provide next-generation genomic...